News

Find News

Filter articles

Showing 3201 to 3210 of 3417 results

Novartis boosts cancer immunotherapy research with CoStim acquisition

US18-02-2014Mergers & acquisitions

Novartis has announced it will acquire biotechnology company CoStim for an undisclosed sum.

Baker & McKenzie adds to IP team

UK17-02-2014

Baker & McKenzie LLP has added to its IP team with the appointment of Hiroshi Sheraton as partner in its London office.

MSF criticises US pressure on Indian patent policy

India, US17-02-2014

Humanitarian organisation Médecins Sans Frontières has criticised the US for pressuring the Indian government to review its patent policies.

Myriad and Gene by Gene settle BRCA litigation

US13-02-2014Legal developments

Myriad and its rival genetic diagnostics company Gene by Gene have agreed to settle their patent infringement case related to BRCA tests.

US Chamber of Commerce slams Indian patent practices

India, US12-02-2014

The US Chamber of Commerce has criticised India’s “recent pattern of pharma patent denials”, which it says “are not about access to medicine”.

Merck and Samsung Bioepis agree diabetes deal

South Korea, US11-02-2014

Pharmaceutical company Merck and Samsung Bioepis, a joint venture between South Korean firm Samsung and Biogen, have agreed to work on a diabetes treatment.

Appeals court ruling blocks Lyrica competition until 2018

US10-02-2014

The US Court of Appeals for the Federal Circuit has upheld a patent covering Pfizer’s pain drug Lyrica, closing the market to any generic challengers until 2018.

Roche sues Mylan over Herceptin biosimilar

India07-02-2014Legal developments

Roche’s Indian subsidiary has sued Mylan and Bangalore-based pharmaceutical company Biocon at the Delhi High Court, for launching a biosimilar of its breast cancer drug Herceptin (trastuzumab).

Myriad Genetics to acquire diagnostic company Crescendo

US06-02-2014Mergers & acquisitions

Myriad Genetics has entered into a definitive agreement to acquire inflammatory and autoimmune diagnostics company Crescendo Bioscience for $270 million.

Baker & McKenzie welcomes pharma lawyer

US05-02-2014

Law firm Baker & McKenzie has hired pharmaceutical lawyer Julian Thurston as a consultant in its global pharmaceutical and healthcare industry group.

Showing 3201 to 3210 of 3417 results

LSIPR